Clinical Trials Browser

INDUSTRY × milatuzumab × Clear all

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01663766 2021-08-19

Phase I Study of Milatuzumab for Graft Versus Host Disease

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00421525 2021-08-16

Phase I/II Study of hLL1 in Multiple Myeloma

Phase 1/2 Completed

25 enrolled

Plasma cell

Multiple Myeloma, Plasmacytoma

Clinical Trials

Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL

Phase I Study of Milatuzumab for Graft Versus Host Disease

Phase I/II Study of hLL1 in Multiple Myeloma